These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4439371)

  • 1. [Treatment of hyperlipidemias. Value of a new hypolipidemic drug clofibride, (M-G. 46)].
    Leutenegger M; Choisy H; Caron J; Paris H
    Therapie; 1974; 29(4):599-610. PubMed ID: 4439371
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experimentation of clofibride. Apropos of 40 cases].
    Warembourg H; Jaillard J
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of clofibrate. The opinion of Prof. D. Kritchevsky].
    Fabbrocini V
    Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692
    [No Abstract]   [Full Text] [Related]  

  • 4. [Medium and long term study of clofibride in the treatment of atherogenic hyperlipidemia. Statistical approach to the results].
    Fromantin M; Garraud R; Auriche M
    Sem Hop Ther; 1976 Nov; 52(9):455-64. PubMed ID: 1006320
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)].
    Fourrier A; Mouton Y
    Lille Med; 1974 Apr; 19(4 Suppl 11):532-7. PubMed ID: 4612283
    [No Abstract]   [Full Text] [Related]  

  • 6. [Index of "unbound" thyroxine in patients with hypercholesterolemia or hypertriglyceridemia treated with clofibrate].
    Felt V; Strasek J; Bednár J
    Cas Lek Cesk; 1972 Sep; 111(40):929-31. PubMed ID: 4628030
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of arteriosclerosis].
    Schwandt P
    Internist (Berl); 1973 Jul; 14(7):325-9. PubMed ID: 4582163
    [No Abstract]   [Full Text] [Related]  

  • 8. [The mechanisms of action of etophylline-clofibrate in hyperlipidemia].
    Păduraru I; Nechifor M; Dănilă G; Jercă L; Filip M; Iacobovici A; Teslaru E; Filip C; Saramet A
    Rev Med Chir Soc Med Nat Iasi; 1993; 97(1):445-9. PubMed ID: 8153471
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of symfibrate in the treatment of hyperlipemias. Preliminary data].
    Giuliani A; Trezzini C; Urbinati G; Conti R
    Clin Ter; 1979 Mar; 88(5):481-9. PubMed ID: 466970
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypolipidemic treatment in renal insufficiency].
    Synková J; Groh J; Brátová M; Zahradník J; Jánská D
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1981; 24(3):385-90. PubMed ID: 6977836
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pyridoxine para-chloro-phenoxy-isobutyrate. Analysis of hypolipidemic effects].
    Mirouze J; Orsetti A; Cartry E
    Nouv Presse Med; 1973 Dec; 2(46):3115-6. PubMed ID: 4787779
    [No Abstract]   [Full Text] [Related]  

  • 12. [The study of clofibrate. The viewpoint of Professor D. Kritchevsky interviewed by V. Fabbrocini].
    Kritchevsky D
    Minerva Med; 1979 Dec; 70(55):3808-9. PubMed ID: 523009
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of clofibrate in hyperlipidemia: a controlled trial.
    Ilyas M; Peracha MA; Ali N; Husnain Sherazi SM; Mahmood N
    J Pak Med Assoc; 1978 Sep; 28(9):126-8. PubMed ID: 105169
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic of acetiromate on hyperlipidemia--comparison with clofibrate using a double-blind method].
    Nakano Y; Fukui I; Niiho S; Kuki H; Takahata J
    Nihon Rinsho; 1974 Jul; 32(7):2526-51. PubMed ID: 4612204
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug treatment of hyperlipidemia.
    Spector AA
    J Iowa Med Soc; 1972 Oct; 62(10):524-5 passim. PubMed ID: 5074337
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the spectrum of serum lipids following 3 months administration of clofibrate Spofa].
    Cagánova A; Cagan S
    Cesk Farm; 1971 Nov; 20(9):341-6. PubMed ID: 5136172
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative double-blind study on the normolipemic effect of clofibrate and a clofibrate-mucopolysaccharide extract combination].
    Cagli V; Lillo V
    Clin Ter; 1975 Oct; 75(2):153-69. PubMed ID: 132333
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dyslipemia and atherosclerotic disease. (Classification, useful determinations and treatment)].
    Naceur MB
    Tunis Med; 1971; 49(6):368-71. PubMed ID: 5152677
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of Clofibrate on disorders in lipid metabolism. I].
    Szybiński Z; Lankosz J; Kieta-Fyda A; Bobrowski A; Biczowa N; Mareczek S
    Przegl Lek; 1971 Oct; 28(10):668-71. PubMed ID: 5136016
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypolipidemic action of simfibrate in diabetic subjects].
    Gragnoli G; Tanganelli I; Signorini AM; Kristodhullu A
    Clin Ter; 1981 Feb; 96(4):397-408. PubMed ID: 7214862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.